Non-Hodgkin lymphoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Preeti Singh (talk | contribs) |
||
| (6 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Non-Hodgkin lymphoma}} | {{Non-Hodgkin lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}} {{shyam}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
Laboratory tests for | Laboratory tests for non-Hodgkin lymphoma include [[complete blood count]] (CBC), blood chemistry studies, [[HIV]] blood test, and [[hepatitis B]] blood test. | ||
==Laboratory Tests== | ==Laboratory Tests== | ||
Laboratory tests for | Laboratory tests for non-Hodgkin lymphoma include the following:<ref name="pmid26174528">{{cite journal| author=Sandlund JT| title=Non-Hodgkin Lymphoma in Children. | journal=Curr Hematol Malig Rep | year= 2015 | volume= 10 | issue= 3 | pages= 237-43 | pmid=26174528 | doi=10.1007/s11899-015-0277-y | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26174528 }} </ref><ref name="pmid22835603">{{cite journal| author=Shankland KR, Armitage JO, Hancock BW| title=Non-Hodgkin lymphoma. | journal=Lancet | year= 2012 | volume= 380 | issue= 9844 | pages= 848-57 | pmid=22835603 | doi=10.1016/S0140-6736(12)60605-9 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22835603 }} </ref><ref name="pmid19999217">{{cite journal| author=Hingorjo MR, Syed S| title=Presentation, staging and diagnosis of lymphoma: a clinical perspective. | journal=J Ayub Med Coll Abbottabad | year= 2008 | volume= 20 | issue= 4 | pages= 100-3 | pmid=19999217 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19999217 }} </ref> | ||
* [[ | |||
===Complete Blood Count=== | |||
* In early stage of the disease the [[complete blood count]] (CBC) may be normal. | |||
*[[Anemia]] may be seen secondary to involvement of [[bone marrow]], [[Autoimmune hemolytic anemia|autoimmune hemolysis]] and bleeding. | |||
*[[Thrombocytopenia]], [[leukopenia]], or [[pancytopenia]] may be seen after bone marrow infiltration or autoimmune cytopenias. | |||
*[[Lymphocytosis]] with circulating malignant cells seen in low grade lymphomas. | |||
*[[Thrombocytosis]] may be seen as a [[paraneoplastic syndrome]]. | |||
===Blood Chemistry Studies=== | |||
* HIV | *Elevated [[lactate dehydrogenase]] (LDH) correlates with poor prognosis. | ||
* Hepatitis B | *[[Liver function test]] (LFT) results may be abnormal secondary to hepatic involvement. | ||
*[[Hypercalcemia]] may be seen in patients with acute form of [[Adult T-cell leukemia|adult T-cell lymphoma-leukemia]] (ATLL). | |||
===Other Studies=== | |||
*Increased levels of [[beta2-microglobulin]] level may be seen, which correlate with a poor prognosis. | |||
*A positive [[Coombs test]] may be positive. | |||
*[[Hypogammaglobulinemia]] may be present. | |||
*[[Human Immunodeficiency Virus (HIV)|HIV]] viral load and the antibody titre may be elevated. | |||
*[[HTLV-1]] serology should be obtained in patients with [[Adult T-cell leukemia|ATLL]]. | |||
*HbsAg and [[Hepatitis B|Hep B]] antibody titre must be obtained. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category: | [[Category:Immunology]] | ||
Latest revision as of 21:00, 21 January 2019
|
Non-Hodgkin lymphoma Microchapters |
|
Differentiating Non-Hodgkin's Lymphoma |
|---|
|
Treatment |
|
Case Studies |
|
Non-Hodgkin lymphoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Non-Hodgkin lymphoma laboratory tests |
|
Risk calculators and risk factors for Non-Hodgkin lymphoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [3]
Overview
Laboratory tests for non-Hodgkin lymphoma include complete blood count (CBC), blood chemistry studies, HIV blood test, and hepatitis B blood test.
Laboratory Tests
Laboratory tests for non-Hodgkin lymphoma include the following:[1][2][3]
Complete Blood Count
- In early stage of the disease the complete blood count (CBC) may be normal.
- Anemia may be seen secondary to involvement of bone marrow, autoimmune hemolysis and bleeding.
- Thrombocytopenia, leukopenia, or pancytopenia may be seen after bone marrow infiltration or autoimmune cytopenias.
- Lymphocytosis with circulating malignant cells seen in low grade lymphomas.
- Thrombocytosis may be seen as a paraneoplastic syndrome.
Blood Chemistry Studies
- Elevated lactate dehydrogenase (LDH) correlates with poor prognosis.
- Liver function test (LFT) results may be abnormal secondary to hepatic involvement.
- Hypercalcemia may be seen in patients with acute form of adult T-cell lymphoma-leukemia (ATLL).
Other Studies
- Increased levels of beta2-microglobulin level may be seen, which correlate with a poor prognosis.
- A positive Coombs test may be positive.
- Hypogammaglobulinemia may be present.
- HIV viral load and the antibody titre may be elevated.
- HTLV-1 serology should be obtained in patients with ATLL.
- HbsAg and Hep B antibody titre must be obtained.
References
- ↑ Sandlund JT (2015). "Non-Hodgkin Lymphoma in Children". Curr Hematol Malig Rep. 10 (3): 237–43. doi:10.1007/s11899-015-0277-y. PMID 26174528.
- ↑ Shankland KR, Armitage JO, Hancock BW (2012). "Non-Hodgkin lymphoma". Lancet. 380 (9844): 848–57. doi:10.1016/S0140-6736(12)60605-9. PMID 22835603.
- ↑ Hingorjo MR, Syed S (2008). "Presentation, staging and diagnosis of lymphoma: a clinical perspective". J Ayub Med Coll Abbottabad. 20 (4): 100–3. PMID 19999217.